Search

everythinglearnresearchcommunity

for

Search:↓

High levels of the protein Flightless I worsen ulcerative colitis symptoms in mice.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

A substance called poly(I:C) increases a protein called carbonic anhydrase II in skin cells, which might help with skin defense and healing.

Children with autoimmune gastritis showed improved intestinal health over time and should be checked for other autoimmune conditions.

White hair follicles in vitiligo have fewer and less functional melanocytes.

A 3-year-old boy lost all his hair due to a rare reaction to phenobarbital, but it grew back after steroid treatment.

CD2 might be a new treatment target for patchy alopecia areata.

Acne is a common skin condition that can be influenced by diet, lifestyle, and hormones, and requires a treatment approach that includes psychological considerations.

iNOS contributes to hair loss in obese diabetic mice and blocking it may encourage hair growth.

Glycemic control medications for Type 2 diabetes can affect skin conditions like psoriasis.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

Erdr1 could be a new marker for diagnosing hair loss.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Human amniotic stem cells can safely treat psoriasis-like skin in mice.

Nail changes are common in alopecia areata and can indicate its severity.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Tattoos may trigger autoimmune symptoms in some people.

Gut microbiota changes might play a role in alopecia areata, and microbiome-targeted treatments show promise.

Mothers with alopecia areata have a higher risk of adverse birth outcomes.

Higher levels of IL-17A and IL-2 are linked to alopecia areata.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Hyaluronic acid and polycaprolactone improve skin regeneration, with polycaprolactone having a stronger effect on healing and tissue repair.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

JAK inhibitors help treat alopecia areata but have high recurrence after stopping.

High TSPEAR levels in colorectal cancer predict worse outcomes.

High TSPEAR levels in colorectal cancer predict worse outcomes.

Stress can cause a type of hair loss in mice lacking the CCHCR1 gene.